PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.730
-0.040 (-0.84%)
At close: Aug 11, 2026, 4:00 PM EDT
4.720
-0.010 (-0.21%)
After-hours: Aug 11, 2026, 7:34 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $90.69 million as of August 11, 2026. Its market cap has increased by 176.38% in one year.
Market Cap
90.69M
Enterprise Value
82.13M
1-Year Change
176.38%
Ranking
Category
Stock Price
$4.73
ChartMarket Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $90.69M, an increase of 10.02%. That is a compound annual growth rate of 1.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 90.69M | 25.62% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 94.23M |
| Tenax Therapeutics | 93.94M |
| Cognition Therapeutics | 92.63M |
| Aldeyra Therapeutics | 91.69M |
| NeOnc Technologies Holdings | 91.29M |
| Verrica Pharmaceuticals | 90.53M |
| Gossamer Bio | 90.24M |
| Adicet Bio | 88.16M |